Literature DB >> 4009572

Cutaneous granulomatous vasculitis: presenting feature of Crohn's disease.

D N Slater, P C Waller, G Reilly.   

Abstract

Entities:  

Mesh:

Year:  1985        PMID: 4009572      PMCID: PMC1291185          DOI: 10.1177/014107688507800714

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Cutaneous polyartheritis nodosa associated with Crohn's disease.

Authors:  N H Dyer; J L Verbov; A M Dawson; P F Borrie; A G Stansfeld
Journal:  Lancet       Date:  1970-03-28       Impact factor: 79.321

2.  Severe cutaneous vasculitis complicating ulcerative colitis.

Authors:  J P Callen
Journal:  Arch Dermatol       Date:  1979-02

3.  Granulomatous perivasculitis in Crohn's disease.

Authors:  W Burgdorf; M Orkin
Journal:  Arch Dermatol       Date:  1981-10

4.  Cutaneous granulomatous vasculitis associated with Crohn's disease.

Authors:  A Chalvardjian; J R Nethercott
Journal:  Cutis       Date:  1982-11
  4 in total
  5 in total

1.  Arthritis or vasculitis as presenting symptoms of Crohn's disease.

Authors:  Reuven Mader; Ori Segol; Muhammed Adawi; Philippe Trougoboff; Elchanan Nussinson
Journal:  Rheumatol Int       Date:  2004-04-20       Impact factor: 2.631

2.  Penile Crohn's disease: a case report.

Authors:  I Neri; F Bardazzi; P A Fanti; M S Guidetti
Journal:  Genitourin Med       Date:  1995-02

3.  Relation of granulomas to lymphatic vessels in Crohn's disease.

Authors:  E E Mooney; J Walker; D O Hourihane
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

4.  Crohn's disease with metastatic cutaneous involvement and granulomatous cheilitis.

Authors:  F M Tatnall; H J Dodd; I Sarkany
Journal:  J R Soc Med       Date:  1987-01       Impact factor: 18.000

Review 5.  Metastatic Crohn's Disease: An Approach to an Uncommon but Important Cutaneous Disorder.

Authors:  Babak Aberumand; Jessica Howard; John Howard
Journal:  Biomed Res Int       Date:  2017-01-03       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.